Outsourcing

Latest News


Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

i1-625569-1408643483742.jpg

Pharma Capsules

Brief pharmaceutical news items for September 2009.

Expansion Plan

Contract-service providers are expanding their offerings in this slow-growth environment.

i3_t-624200-1408645417618.jpg

A Brave New Path for Pharma

Personalized medicine and integrated healthcare delivery require new business and pricing models. This article contains bonus online-exclusive material.

i4-623094-1408642778074.jpg

The author reviews the major biopharmaceutical markets' activity and predicts how the markets may evolve.

i1-621295-1408645170266.jpg

Expansion plan

Pharmaceutical Technology Europe

In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.

ePT--the Electronic Newsletter of Pharmaceutical Technology

Eastern Europe's pharmaceutical market is forecast to grow at a CAGR of more than 10% to be worth more than $41 billion by 2014, according to a report from companiesandmarkets.com.

Pharmaceutical Technology Europe PTE

Only 43% of European Chief Financial Officers (CFOs) and Chief Information Officers (CIOs) have tried to calculate the impact of outsourcing on their company, and of those that have tried, only 1 in 5 are confident in their sums, according to a study by Cognizant.